AG
TXG icon

Algert Global’s 10x Genomics TXG Stock Holding History

Algert Global’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Sell
49,566
-97,744
-66% -$2.56M 0.02% 849
2026
Q1 		$3.13M Sell
147,310
-242,970
-62% -$4.86M 0.05% 585
2025
Q4 		$6.37M Sell
390,280
-184,160
-32% -$2.78M 0.1% 348
2025
Q3 		$6.72M Sell
574,440
-705,428
-55% -$9.2M 0.11% 311
2025
Q2 		$14.8M Buy
1,279,868
+826,581
+182% +$7.53M 0.31% 51
2025
Q1 		$3.96M Sell
453,287
-207,333
-31% -$2.61M 0.1% 353
2024
Q4 		$9.49M Buy
660,620
+289,662
+78% +$4.57M 0.22% 122
2024
Q3 		$8.38M Buy
370,958
+252,994
+214% +$5.23M 0.23% 118
2024
Q2 		$2.29M Buy
117,964
+33,364
+39% +$874K 0.08% 425
2024
Q1 		$3.18M Buy
84,600
+59,360
+235% +$2.61M 0.12% 276
2023
Q4 		$1.41M Buy
25,240
+4,850
+24% +$211K 0.06% 523
2023
Q3 		$841K Sell
20,390
-21,721
-52% -$1.13M 0.04% 605
2023
Q2 		$2.35M Sell
42,111
-9,043
-18% -$489K 0.1% 343
2023
Q1 		$2.85M Buy
+51,154
New +$2.39M 0.13% 230

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Algert Global's TXG Position: Q2 2026 in Review

Algert Global reduced its 10x Genomics (TXG) stake by 66% in Q2 2026, selling an estimated $2.56M and leaving 49,566 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #849.

Algert Global first reported a position in TXG in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.8M in Q2 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Algert Global held 49,566 shares of 10x Genomics worth $1.9M as of Q2 2026.
  • Algert Global sold 97,744 10x Genomics shares in Q2 2026, an estimated $2.56M.
  • 10x Genomics made up 0.02% of Algert Global's portfolio in Q2 2026, its #849 holding.
  • Algert Global first reported a position in 10x Genomics in Q1 2023 and has held it in 14 quarters since.
  • Algert Global's 10x Genomics position peaked at $14.8M in Q2 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.